AllSeq is proud to be a media partner for SelectBio’s upcoming “Next Generation Sequencing & Single Cell Analysis” conference that will be right here in San Diego on September 28th-30th. One of the benefits (in addition to the 15% discount we were able to negotiate for our readers) was the opportunity to interview a few of the keynote speakers. Check out our interviews with Dr. Jennifer Friedman from the Rady Children's Hospital in San Diego and Dr. Nazneen Aziz from the Phoenix Children’s Hospital. We ask both of them about how they’re using NGS in a clinical setting and their thoughts on what’s preventing it from being more widely adopted.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM